Avoid platforms that issue prescriptions after questionnaire-only review with no physician interaction
These effects are seen even outside of diabetes control.[ref] Decreased colon cancer mortality: A 5-year mortality study in colon cancer patients showed that GLP-1 RA use decreased mortality risk by 60% in obese patients.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)
Considerations for specific populations Despite the adherence improvement and convenience of GLP-1 patches, they may not be the best option for some people, including: Elderly patients usually have frail skin, making it challenging to apply and remove the transdermal patch
Several years ago, the FDA began allowing [archived link] certain types (503A) of compounding pharmacies to make and sell copies of some branded GLP-1 RA products that were in shortage
It doesnt offer prescriptions, medical supervision, or medications like Ozempic, Wegovy, or Mounjaro
Lower cardiovascular risk: Studies show a 20% reduced risk of heart attack or stroke in people with obesity, and 26% in those with both obesity and diabetes